Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00482_DB00755_nanopub.RAApfkMVYldrMOEC4kDIvC6nGl7bC8Ha11-oeDwi6-_Ww#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00482_DB00755 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00482_DB00755 label "DDI between Celecoxib and Tretinoin - The moderate CYP2C8 inhibitor, Celecoxib, may decrease the metabolism and clearance of oral Tretinoin. Monitor for changes in Tretinoin effectiveness and adverse/toxic effects if Celecoxib is initiated, discontinued to dose changed. [drugbank_resource:DB00482_DB00755]" assertion.
- drugbank_resource:DB00482_DB00755 identifier "drugbank_resource:DB00482_DB00755" assertion.
- drugbank_resource:DB00482_DB00755 title "DDI between Celecoxib and Tretinoin - The moderate CYP2C8 inhibitor, Celecoxib, may decrease the metabolism and clearance of oral Tretinoin. Monitor for changes in Tretinoin effectiveness and adverse/toxic effects if Celecoxib is initiated, discontinued to dose changed." assertion.
- drugbank:DB00482 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00482_DB00755 assertion.
- drugbank:DB00755 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00482_DB00755 assertion.